EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advanced Progress in the Role of Adipose-Derived Mesenchymal Stromal/Stem Cells in the Application of Central Nervous System Disorders

Haiyue Wu, Yishu Fan iD, Mengqi Zhang

Pharmaceutics · 16.11.2023 · 15 (11) · 2637

DOI: 10.3390/pharmaceutics15112637 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 16.11.2023. Verfasst von Haiyue Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xiangya Hospital, Central South University, Changsha 410008, China. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundations for Excellent Young Scholars of Hunan Province, Key Research and Development Program of Hunan Province, Research Project on Education and Teaching Innovation of Central South University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Currently, adipose-derived mesenchymal stromal/stem cells (ADMSCs) are recognized as a highly promising material for stem cell therapy due to their accessibility and safety. Given the frequently irreversible damage to neural cells associated with CNS disorders, ADMSC-related therapy, which primarily encompasses ADMSC transplantation and injection with exosomes derived from ADMSCs or secretome, has the capability to inhibit inflammatory response and neuronal apoptosis, promote neural regeneration, as well as modulate immune responses, holding potential as a comprehensive approach to treat CNS disorders and improve prognosis. Empirical evidence from both experiments and clinical trials convincingly demonstrates the satisfactory safety and efficacy of ADMSC-related therapies. This review provides a systematic summary of the role of ADMSCs in the treatment of central nervous system (CNS) disorders and explores their therapeutic potential for clinical application. ADMSC-related therapy offers a promising avenue to mitigate damage and enhance neurological function in central nervous system (CNS) disorders. However, further research is necessary to establish the safety and efficacy of clinical ADMSC-based therapy, optimize targeting accuracy, and refine delivery approaches for practical applications.

Schlagwörter

Stichwörter der Autor:innen

adipose-derived mesenchymal stromal/stem cellscentral nervous system injuryclinical trialepilepsymultiple sclerosisneurodegenerative disease

Autor:innen und Institutionen

  • Department of Neurology, Xiangya Hospital, Central South University, Changsha 410008, China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, China.

ORCID-Profile: Yishu Fan

Förderung

  • Natural Science Foundations for Excellent Young Scholars of Hunan Province
  • Key Research and Development Program of Hunan Province
  • Research Project on Education and Teaching Innovation of Central South University
  • Natural Science Foundations of Hunan Province
  • National Natural Science Foundation of China

Zitieren

APA

Wu, H., Fan, Y., & Zhang, M. (2023). Advanced Progress in the Role of Adipose-Derived Mesenchymal Stromal/Stem Cells in the Application of Central Nervous System Disorders. Pharmaceutics, 15(11), 2637. https://doi.org/10.3390/pharmaceutics15112637

Vancouver

Wu H, Fan Y, Zhang M. Advanced Progress in the Role of Adipose-Derived Mesenchymal Stromal/Stem Cells in the Application of Central Nervous System Disorders. Pharmaceutics. 2023;15(11):2637. doi:10.3390/pharmaceutics15112637

BibTeX
@article{Wu2023,
  author = {Wu, Haiyue and Fan, Yishu and Zhang, Mengqi},
  title = {Advanced Progress in the Role of Adipose-Derived Mesenchymal Stromal/Stem Cells in the Application of Central Nervous System Disorders},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {11},
  pages = {2637},
  doi = {10.3390/pharmaceutics15112637}
}
Kostenlos starten →